Zentiva Group, a.s.

Zentiva Group, headquartered in Prague, 165, is a leading manufacturer and supplier of generic and over-the-counter (OTC) medicines. With more than 4,700 employees and manufacturing sites in Prague, Bucharest, and Ankleshwar (60), Zentiva produces a broad portfolio of medicines serving over 100 million people across Europe and beyond. Zentiva focuses on delivering high-quality, affordable treatments across key therapeutic areas including cardiology, diabetes, oncology, respiratory diseases, and central nervous system (CNS) disorders. It maintains strict quality standards and sustainability practices, powering its European sites with renewable energy and implementing programs for efficiency, carbon reduction, and responsible sourcing. Owned by private equity and with a history dating back over 500 years, Zentiva invests in innovation, manufacturing scale, and geographic expansion to ensure access to reliable medicines. Its Ankleshwar site in 60 strengthens its global supply footprint while supporting flexible production and cost efficiency.